Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Put Your School on the Map
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
Media Kit
Advertising Guide
Manufacturer Partnership
Subscribe to our newsletter
Put Your School on the Map
Contact Us
Resources
FAQ
Tools for Schools
Coupons
Search
Home
Tags
Palforzia (AR101)
Tag: Palforzia (AR101)
Nestlé to Acquire Aimmune Therapeutics
News Wire ~ 3rd Party Press Release
-
2020/08/31
0
Results of Aimmune’s Pivotal Phase 3 European Trial of PALFORZIA® Published...
News Wire ~ 3rd Party Press Release
-
2020/07/21
0
New Two-Year PALFORZIA™ Data Show On-going Safety and Efficacy and Continued...
News Wire ~ 3rd Party Press Release
-
2020/06/08
0
Aimmune Warns Coronavirus Will Slow Marketing of Palforzia Treatment for Peanut...
Dave Bloom
-
2020/03/17
0
Aimmune Provides FDA Mandated Program for Patients Considering Treatment of Peanut...
Dave Bloom
-
2020/02/23
0
Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...
News Wire ~ 3rd Party Press Release
-
2020/02/05
0
What You Need to Know About the First Peanut Allergy Treatment...
News Wire ~ 3rd Party Press Release
-
2020/02/03
0
FDA Approves Aimmune’s PALFORZIA as First Treatment for Peanut Allergy
News Wire ~ 3rd Party Press Release
-
2020/01/31
0
1
2
Page 2 of 2